User Information: Package Insert
1.What is Calcio/Vitamina D3 Kern Pharma and how is it used
2.What you need to know before starting to take Calcio/Vitamina D3 Kern Pharma
3.How to take Calcio/Vitamina D3 Kern Pharma
4.Possible adverse effects
5.Storage of Calcio/Vitamina D3 Kern Pharma
6.Contents of the package and additional information
This medication is an association of Calcium and Vitamin D.
This medication is indicated for the treatment of calcium and vitamin D deficiency states.3.
This medication may also be used as a vitamin D and calcium supplement in the treatment of osteoporosis in patients with manifest calcium and vitamin D deficiency or with a high risk of developing it.
Ask your doctor, pharmacist, or other healthcare personnel if you have any doubts and always follow their instructions.
Consult your doctor or pharmacist before starting to take Calcio/Vitamina D3 Kern Pharma.
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
The effect of treatment may be affected if this medication is taken simultaneously with other medications:
Please ensure that your doctor knows if you are taking any of the medications listed above. Your dose may need to be adjusted.
If you are taking medications for osteoporosis (bisphosphonates) simultaneously, you should take it at least one hour before taking Calcio/Vitamina D3 Kern Pharma.
If you are taking medications for infection (fluoroquinolones) simultaneously, you should take it two hours before or six hours after taking Calcio/Vitamina D3 Kern Pharma.
If you are taking medications for infection (tetracyclines) simultaneously, you should take it two hours before or six hours after taking Calcio/Vitamina D3 Kern Pharma.
If you are taking medications for dental caries (sodium fluoride) or anemia (iron) simultaneously, you should take it at least three hours before taking Calcio/Vitamina D3 Kern Pharma.
If you are taking medications for hypothyroidism (levothyroxine) simultaneously, you should separate the intake of Calcio/Vitamina D3 Kern Pharma by at least four hours.
The absorption of calcium may be inhibited by foods containing oxalic acid (present in spinach and rhubarb) or phytic acid (present in most cereals). It is recommended not to take Calcio/Vitamina D3 Kern Pharma during the two hours following the consumption of foods with high oxalic acid or phytic acid content.
During treatment with Calcio/Vitamina D3 Kern Pharma, do not take foods that may be "fortified" with vitamin D.
During pregnancy, the daily intake should not exceed 1500 mg of calcium and 600 IU of vitamin D.
The use of Calcio/Vitamina D3 Kern Pharma is not recommended during pregnancy.
Calcio/Vitamina D3 Kern Pharma can be taken during breastfeeding. Calcium and vitamin D3 pass into breast milk. This should be taken into account when additional vitamin D is provided to the infant.
If you are pregnant or breastfeeding, believe you may be pregnant, or intend to become pregnant, consult your doctor before using this medication.
Driving and operating machinery
No effects have been observed on the ability to drive and operate machinery. |
This medication contains aspartame
Aspartame is a source of phenylalanine. Phenylalanine may be harmful to people with phenylketonuria.
This medication contains sorbitol, lactose, and saccharose
If your doctor has told you that you have intolerance to some sugars, contact your doctor before taking this medication.
This medication contains soy oil
If you are allergic to peanuts or soy, do not take this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is established by your doctor for you individually.
The usual dose is: 1 to 2 tablets per day.
The tablets should be chewed and then, if desired, a small amount of water can be consumed.
The tablets can also be placed in a half glass of water and once dissolved in it, the contents can be consumed.
Calcio/Vitamina D3 Kern Pharma is not indicated for children.
Call your doctor or pharmacist immediately if you take more of this medication than prescribed by your doctor. You can also contact the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
The symptoms of a possible overdose of Calcio/Vitamina D3 Kern Pharma may include loss of appetite, abnormal emission of large amounts of urine, nausea, vomiting, and constipation.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Calcio/Vitamina D3 Kern Pharma may produce adverse effects, although not all people will experience them.
You should stop taking Calcio/Vitamina D3 Kern Pharma and immediately inform your doctor if you experience severe allergic reaction symptoms such as:
Less common adverse effects (may affect up to 1 in 100 patients):hypercalcemia (elevated calcium levels in serum) and/or hypercalciuria (elevated calcium levels in urine).
Rare adverse effects (may affect up to 1 in 1,000 patients):constipation, flatulence, nausea, abdominal pain, and diarrhea.
Unknown adverse effects (cannot be estimated with available data):severe allergic reactions.
If you experience adverse effects, consult your doctor or pharmacist, even if they are not listed in this prospectus.
Composition of Contents of the packaging and additional information / Additional information
The active principles are calcium carbonate 1500 mg corresponding to 600 mg of calcium and colecalciferol 0.01 mg corresponding to 400 UI of vitamin D.
The other components are: sodium croscarmellose, maltodextrin, cornstarch, aspartame (E-951), sorbitol (E-420), sodium saccharin, lactose monohydrate, anise essence, peppermint essence, molasses essence, magnesium stearate, all-rac-α-tocopherol, silicon dioxide, partially hydrogenated soybean oil, gelatin, and sucrose.
Appearance of Contents of the packaging and additional information / Additional information and contents of the packaging
Contents of the packaging and additional information / Additional information are presented in the form of chewable tablets for oral administration.
Container of 60 tablets.
Only some packaging sizes may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
KERN PHARMA, S.L.
Venus, 72. Poligono Industrial Colon II.
08228– Tarrasa, Barcelona
Spain
Responsible for manufacturing:
ITALFARMACO, S.p.A.
Viale Fulvio Testi 330
Milan (ITALY)
Tel.: 39 02 6443.1
Date of the last review of this prospectus:July 2013
The detailed information of this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.